Marco Iansiti

Marco is the David Sarnoff Professor of Business Administration at Harvard Business School, where he heads the Technology and Operations Management Unit and the Digital Initiative.  He co-founded Keystone Strategy in 2003 and serves as the Chairman of the Board of Directors.

An expert on digital innovation and transformation, Marco has a special focus on strategy, business models, and new product development in high technology industries. He is the author or coauthor of more than 100 publications. His second book, The Keystone Advantage: What the New Dynamics of Business Ecosystems Mean for Strategy, Innovation, and Sustainability was selected as one of the 10 best business books of the year in 2004 by Strategy and Business. Marco advises a variety of Fortune 500 companies with a focus on digital strategies and transformation. He has been a faculty member at Harvard Business School since 1989.

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More

If Private Sector R&D Is the Future, IP Policy Must Catch Up

By Chris Borges The President’s Budget Request for fiscal year 2026 (FY 2026) includes steep cuts to federal research and development (R&D) funding—a troubling signal for U.S. innovation and economic security. While congressional committees may push back on the most severe reductions, the signs are clear: Federal R&D funding is likely
Read More

Don’t Tax Invention: The Risks of a Patent Tax

By Sujai Shivakumar and Chris Borges The Commerce Department is reportedly considering a novel revenue-raising idea to address the national debt: a “patent tax.” Under this proposal, patent holders would be required to pay the federal government between 1 and 5 percent of their patents’ assessed value each year. While the
Read More